跳至主要内容
临床试验/NCT02023775
NCT02023775已完成不适用

Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™

Medtronic Cardiac Rhythm and Heart Failure10 个研究点 分布在 1 个国家目标入组 409 人开始时间: 2010年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
409
试验地点
10
主要终点
absence of re-intervention on the pulmonary valve

研究概览

简要总结

Prospective, longitudinal, open-label, multicentre, observational, non-comparative national study using an exhaustive registry of implantations over a given period.

This study is requested by French Health Authorities for reimbursement renewal, to maintain reimbursement for pulmonary valvular replacement by bioprothesis in approved indication in France.

详细描述

This is a prospective, longitudinal, open-label, multicentre, observational, non-comparative national study using an exhaustive registry of implantations over a given period in France. The study is requested by French Health Authorities in 2010 for reimbursement renewal, to maintain reimbursement for pulmonary valvular replacement by bioprothesis in approved indication in France. The study was closed in 2013.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients requiring pulmonary valvular replacement for correction of right ventricular ejection path malfunction (stenosis and/or pulmonary regurgitation).

排除标准

  • Patient or legal representative refusal to data collection or processing
  • Patient unable to guarantee follow-up data collection, in particular for patients living abroad

结局指标

主要结局

absence of re-intervention on the pulmonary valve

时间窗: 12 months

to evaluate the efficacy of the MELODY valve, defined as the absence of re-intervention on the pulmonary valvee

次要结局

  • rate re-intervention on the valve(60 months)
  • patient characteristics(60 months)
  • survival rate at 12, 36, 48 and 60 months(60 months)
  • frequency of antiplatelet treatment during and after implant(60 months)
  • Description and time of onset of open surgery after implantation(60 months)
  • failures of the implantation procedure(60 months)
  • patients' characteristics to indications of the MELODY™ bioprosthesis(60 months)
  • time period before the resumption of professional, university or scholastic activity(60 months)
  • time period before re-intervention on the valve(60 months)

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验